![Andrew L. Strong](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Andrew L. Strong
Fondatore presso K2 Biolabs LLC
Profilo
Andrew L.
Strong is the founder of K2 Biolabs LLC.
He is currently a Director at Medicenna Therapeutics, Inc. and a Partner at Pillsbury Winthrop Shaw Pittman LLP.
Previously, he served as President & Chief Executive Officer at FUJIFILM Diosynth Biotechnologies Texas LLC, Independent Non-Executive Director at Braemar Hotels & Resorts, Inc., Independent Non-Executive Director at Medicenna Therapeutics Corp., and Managing Partner at Campbell George & Strong LLP.
He also served as General Counsel & Compliance Officer at The Texas A&M University System.
Mr. Strong received his undergraduate degree from Texas A&M University and his graduate degree from Houston College of Law in 1994.
Posizioni attive di Andrew L. Strong
Società | Posizione | Inizio |
---|---|---|
Pillsbury Winthrop Shaw Pittman LLP
![]() Pillsbury Winthrop Shaw Pittman LLP Miscellaneous Commercial ServicesCommercial Services Pillsbury Winthrop Shaw Pittman LLP provides legal services. It offers services in education, aviation, communications, consumer and retails, corporate and securities, hospital and intellectual property. The company was founded in 1868 and is headquartered in New York, NY. | Corporate Officer/Principal | 25/03/2015 |
Medicenna Therapeutics, Inc.
![]() Medicenna Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Medicenna Therapeutics, Inc. develops and commercializes therapeutics for the treatment of central nervous system and urological cancers. It also develops proprietary therapeutic cytokines called Superkines, Superkines is powerful immune-system modulators that have significant therapeutic potential for the treatment of many forms of cancer and selected other diseases. Superkines can be fused to tumor cell-killing payloads to form Medicenna's proprietary Empowered Cytokines (EC's). The firm's EC's are being developed for the targeted treatment of cancer and are potentially vastly superior alternatives to other targeted cancer therapies such as Antibody Drug Conjugates. The company was founded by Fahar Merchan and Rosemina Merchant in 2011 and is headquartered in Vancouver, CA. | Direttore/Membro del Consiglio | - |
K2 Biolabs LLC
![]() K2 Biolabs LLC Miscellaneous Commercial ServicesCommercial Services K2 Biolabs LLC is an early-stage life science company that aims to develop the next generation of therapies to improve the lives of patients. The company is based in Houston, TX. K2 Biolabs was founded by Kieron Jones, Andrew L. Strong, and Kevin M. Slawin, with Kieron Jones serving as the CEO since incorporation. | Fondatore | - |
Precedenti posizioni note di Andrew L. Strong
Società | Posizione | Fine |
---|---|---|
MEDICENNA THERAPEUTICS CORP. | Direttore/Membro del Consiglio | 30/09/2020 |
BRAEMAR HOTELS & RESORTS INC. | Direttore/Membro del Consiglio | 01/05/2017 |
FUJIFILM Diosynth Biotechnologies Texas LLC
![]() FUJIFILM Diosynth Biotechnologies Texas LLC Pharmaceuticals: OtherHealth Technology Fujifilm Diosynth Biotechnology Texas LLC manufactures and distributes biopharmaceutical vaccines. The company was founded on February 25, 2011 and is headquartered in College Station, TX. | Amministratore Delegato | 01/03/2015 |
The Texas A&M University System | Responsabile della Conformità | 01/01/2011 |
Campbell George & Strong LLP | Corporate Officer/Principal | 01/01/2005 |
Formazione di Andrew L. Strong
Texas A&M University | Undergraduate Degree |
Houston College of Law | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
BRAEMAR HOTELS & RESORTS INC. | Finance |
MEDICENNA THERAPEUTICS CORP. | Health Technology |
Aziende private | 6 |
---|---|
FUJIFILM Diosynth Biotechnologies Texas LLC
![]() FUJIFILM Diosynth Biotechnologies Texas LLC Pharmaceuticals: OtherHealth Technology Fujifilm Diosynth Biotechnology Texas LLC manufactures and distributes biopharmaceutical vaccines. The company was founded on February 25, 2011 and is headquartered in College Station, TX. | Health Technology |
Pillsbury Winthrop Shaw Pittman LLP
![]() Pillsbury Winthrop Shaw Pittman LLP Miscellaneous Commercial ServicesCommercial Services Pillsbury Winthrop Shaw Pittman LLP provides legal services. It offers services in education, aviation, communications, consumer and retails, corporate and securities, hospital and intellectual property. The company was founded in 1868 and is headquartered in New York, NY. | Commercial Services |
The Texas A&M University System | Finance |
Campbell George & Strong LLP | |
Medicenna Therapeutics, Inc.
![]() Medicenna Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Medicenna Therapeutics, Inc. develops and commercializes therapeutics for the treatment of central nervous system and urological cancers. It also develops proprietary therapeutic cytokines called Superkines, Superkines is powerful immune-system modulators that have significant therapeutic potential for the treatment of many forms of cancer and selected other diseases. Superkines can be fused to tumor cell-killing payloads to form Medicenna's proprietary Empowered Cytokines (EC's). The firm's EC's are being developed for the targeted treatment of cancer and are potentially vastly superior alternatives to other targeted cancer therapies such as Antibody Drug Conjugates. The company was founded by Fahar Merchan and Rosemina Merchant in 2011 and is headquartered in Vancouver, CA. | Health Technology |
K2 Biolabs LLC
![]() K2 Biolabs LLC Miscellaneous Commercial ServicesCommercial Services K2 Biolabs LLC is an early-stage life science company that aims to develop the next generation of therapies to improve the lives of patients. The company is based in Houston, TX. K2 Biolabs was founded by Kieron Jones, Andrew L. Strong, and Kevin M. Slawin, with Kieron Jones serving as the CEO since incorporation. | Commercial Services |
- Borsa valori
- Insiders
- Andrew L. Strong